Health Trials

Colon Cancer Adenocarcinoma

2

Review clinical trials related to Colon Cancer Adenocarcinoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.

The aim of this study is to evaluate the activity of first-line trastuzumab-deruxtecan, capecitabine and bevacizumab in terms of overall response rate for patients with HER-2 positive metastatic/locally advanced unresectable colorectal cancer

Participants needed: 42
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Gruppo Oncologico del Nord-OvestUpdated: Feb 17, 2026Locations: 28
Eligibility criteria

Written informed consent obtained from the patient/legal representative before p... [+31]

Have previously received any systemic anticancer therapy for CRC in the metastat... [+35]

Read more
Status: Not yet recruiting

A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer

This study is a phase Ib/II study to evaluate the efficacy, safety and tolerance of HLX43 combined with HLX07 or Serplulimab in patients with advanced or metastatic colorectal cancer failed or intolerance to standard first-line therapy

Participants needed: 126
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Henlius BiotechUpdated: Jan 22, 2026Locations: 1
Eligibility criteria

Histologically or cytologically confirmed advanced or metastatic colorectal aden... [+4]

Prior exposure to any drug targeting topoisomerase I, including chemotherapy or... [+6]

Read more